Collectively, these data suggest that while alexidine dihydrochloride may be a novel therapeutic for sensitizing tumor cells to chemotherapy, this sensitization is probably functions largely independent of PTPMT1 expression in cells. Here, PTPMT1 is linked to neoplasm.